Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06787183 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Dec 1, 2027 to Dec 1, 2026
    • Start date changed from estimate of Mar 1, 2025 to Dec 1, 2025
    • Study sites: 1 to 2
    • Study completion date: Dec 1, 2027 to Dec 1, 2029
  2. Primary endpoint revised
    • Secondary endpoints expanded, about 10 words
    • Study title expanded, about 2 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To enhance the treatment efficacy of rectal cancer liver metastasis through a multidisciplinary approach of radiotherapy, immunotherapy, and chemotherapy, and to provide a new direction for the combination treatment strategy.
Trial Details
NCT Number NCT06787183
Lead Sponsor Fujian Cancer Hospital
Conditions
(from sponsor)		 Locally Advanced Rectal Cancer With Liver Metastases
Enrollment 42 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov